1. Home
  2. XLO vs SCOR Comparison

XLO vs SCOR Comparison

Compare XLO & SCOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XLO
  • SCOR
  • Stock Information
  • Founded
  • XLO 2016
  • SCOR 1999
  • Country
  • XLO United States
  • SCOR United States
  • Employees
  • XLO N/A
  • SCOR N/A
  • Industry
  • XLO Biotechnology: Pharmaceutical Preparations
  • SCOR Business Services
  • Sector
  • XLO Health Care
  • SCOR Consumer Discretionary
  • Exchange
  • XLO Nasdaq
  • SCOR Nasdaq
  • Market Cap
  • XLO 35.7M
  • SCOR 34.6M
  • IPO Year
  • XLO 2021
  • SCOR 2007
  • Fundamental
  • Price
  • XLO $0.81
  • SCOR $8.06
  • Analyst Decision
  • XLO Buy
  • SCOR
  • Analyst Count
  • XLO 2
  • SCOR 0
  • Target Price
  • XLO $3.00
  • SCOR N/A
  • AVG Volume (30 Days)
  • XLO 453.9K
  • SCOR 156.0K
  • Earning Date
  • XLO 11-06-2025
  • SCOR 11-11-2025
  • Dividend Yield
  • XLO N/A
  • SCOR N/A
  • EPS Growth
  • XLO N/A
  • SCOR N/A
  • EPS
  • XLO N/A
  • SCOR N/A
  • Revenue
  • XLO $15,001,000.00
  • SCOR $358,513,000.00
  • Revenue This Year
  • XLO $519.70
  • SCOR $3.45
  • Revenue Next Year
  • XLO $44.57
  • SCOR $2.59
  • P/E Ratio
  • XLO N/A
  • SCOR N/A
  • Revenue Growth
  • XLO 536.45
  • SCOR N/A
  • 52 Week Low
  • XLO $0.62
  • SCOR $4.39
  • 52 Week High
  • XLO $1.70
  • SCOR $10.18
  • Technical
  • Relative Strength Index (RSI)
  • XLO 62.62
  • SCOR 61.47
  • Support Level
  • XLO $0.79
  • SCOR $8.31
  • Resistance Level
  • XLO $0.91
  • SCOR $10.18
  • Average True Range (ATR)
  • XLO 0.04
  • SCOR 0.52
  • MACD
  • XLO 0.00
  • SCOR 0.13
  • Stochastic Oscillator
  • XLO 50.46
  • SCOR 48.06

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

About SCOR comScore Inc.

comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.

Share on Social Networks: